These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 31094808

  • 21. Regulation of Pleiotrophin, Midkine, Receptor Protein Tyrosine Phosphatase β/ζ, and Their Intracellular Signaling Cascades in the Nucleus Accumbens During Opiate Administration.
    García-Pérez D, Laorden ML, Milanés MV.
    Int J Neuropsychopharmacol; 2015 Jul 11; 19(1):. PubMed ID: 26164717
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Early-life experience decreases drug-induced reinstatement of morphine CPP in adulthood via microglial-specific epigenetic programming of anti-inflammatory IL-10 expression.
    Schwarz JM, Hutchinson MR, Bilbo SD.
    J Neurosci; 2011 Dec 07; 31(49):17835-47. PubMed ID: 22159099
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Exposure to morphine-associated cues increases mu opioid receptor mRNA expression in the nucleus accumbens of Wistar Kyoto rats.
    Dennis TS, Beck KD, Cominski TP, Bobzean SAM, Kuzhikandathil EV, Servatius RJ, Perrotti LI.
    Behav Brain Res; 2016 Oct 15; 313():208-213. PubMed ID: 27421830
    [Abstract] [Full Text] [Related]

  • 26. Withdrawal from dependence upon butorphanol uniquely increases kappa(1)-opioid receptor binding in the rat brain.
    Fan LW, Tanaka S, Tien LT, Ma T, Rockhold RW, Ho IK.
    Brain Res Bull; 2002 Jun 15; 58(2):149-60. PubMed ID: 12127012
    [Abstract] [Full Text] [Related]

  • 27. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
    Cavun S, Göktalay G, Millington WR.
    J Pharmacol Exp Ther; 2005 Nov 15; 315(2):949-58. PubMed ID: 16079299
    [Abstract] [Full Text] [Related]

  • 28. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis.
    Sinchaisuk S, Ho IK, Rockhold RW.
    Pharmacol Biochem Behav; 2002 Dec 15; 74(1):241-52. PubMed ID: 12376173
    [Abstract] [Full Text] [Related]

  • 29. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
    Crain SM, Shen KF.
    Brain Res; 2007 Sep 05; 1167():31-41. PubMed ID: 17692296
    [Abstract] [Full Text] [Related]

  • 30. Intravenous dezocine for postoperative pain: a double-blind, placebo-controlled comparison with morphine.
    Pandit UA, Kothary SP, Pandit SK.
    J Clin Pharmacol; 1986 Apr 05; 26(4):275-80. PubMed ID: 2871049
    [Abstract] [Full Text] [Related]

  • 31. Sex-related differences in the antinociceptive effects of opioids: importance of rat genotype, nociceptive stimulus intensity, and efficacy at the mu opioid receptor.
    Cook CD, Barrett AC, Roach EL, Bowman JR, Picker MJ.
    Psychopharmacology (Berl); 2000 Jul 05; 150(4):430-42. PubMed ID: 10958085
    [Abstract] [Full Text] [Related]

  • 32. Buprenorphine blocks withdrawal in morphine-dependent rat pups.
    Stoller DC, Smith FL.
    Paediatr Anaesth; 2004 Aug 05; 14(8):642-9. PubMed ID: 15283822
    [Abstract] [Full Text] [Related]

  • 33. Assessment of dezocine for morphine-like subjective effects and miosis.
    Jasinski DR, Preston KL.
    Clin Pharmacol Ther; 1985 Nov 05; 38(5):544-8. PubMed ID: 2865027
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Attenuation of morphine tolerance and withdrawal syndrome by coadministration of nalbuphine.
    Jang S, Kim H, Kim D, Jeong MW, Ma T, Kim S, Ho IK, Oh S.
    Arch Pharm Res; 2006 Aug 05; 29(8):677-84. PubMed ID: 16964763
    [Abstract] [Full Text] [Related]

  • 36. Kappa-opioid receptor antagonism in the nucleus accumbens shell distinguishes escalated alcohol consumption and negative affective-like behavior from physiological withdrawal in alcohol-dependence.
    Lepreux G, Henricks AM, Wei G, Go BS, Erikson CM, Abella RM, Pham A, Walker BM.
    Pharmacol Biochem Behav; 2024 Oct 05; 243():173840. PubMed ID: 39096973
    [Abstract] [Full Text] [Related]

  • 37. Oleoyl glycine: interference with the aversive effects of acute naloxone-precipitated MWD, but not morphine reward, in male Sprague-Dawley rats.
    Petrie GN, Wills KL, Piscitelli F, Smoum R, Limebeer CL, Rock EM, Humphrey AE, Sheppard-Perkins M, Lichtman AH, Mechoulam R, Di Marzo V, Parker LA.
    Psychopharmacology (Berl); 2019 Sep 05; 236(9):2623-2633. PubMed ID: 30993360
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.
    Noble F, Cox BM.
    Br J Pharmacol; 1996 Jan 05; 117(1):161-9. PubMed ID: 8825358
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.